À¶Ý®ÊÓƵ

Try our Advanced Search for more refined results

Glenmark Can't Start Selling MS Drug Amid Biogen Fight

By Hanna Vioque ( July 29, 2025, 12:44 AM BST) -- Glenmark has failed to shake off a sales ban and a $1 million fine over its multiple sclerosis treatment after a Swedish appellate court ruled that it couldn't market the generic version as long as Biogen's patent for its blockbuster drug Tecfidera was still in force. ...

À¶Ý®ÊÓƵ is on it, so you are, too.

A À¶Ý®ÊÓƵ subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A À¶Ý®ÊÓƵ subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience À¶Ý®ÊÓƵ today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Companies

Government Agencies